Susquehanna International Group
PROF

Susquehanna International Group’s Profound Medical PROF Stock Holding History

Susquehanna International Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45,100
Closed -$506K – 13767
2021
Q4 		$506K Sell
45,100
-2,800
-6% -$35K ﹤0.01% 9182
2021
Q3 		$701K Buy
47,900
+35,200
+277% +$536K ﹤0.01% 8504
2021
Q2 		$208K Buy
+12,700
New +$236K ﹤0.01% 11525

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Susquehanna International Group's PROF Position: Q1 2026 in Review

Susquehanna International Group sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 28,853 shares — an estimated $227K sold.

Susquehanna International Group first reported a position in PROF in Q4 2020 and held it in 6 quarters. The position peaked at $466K in Q1 2021. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Susquehanna International Group reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 28,853 Profound Medical shares in Q1 2026, an estimated $227K.
  • Susquehanna International Group first reported a position in Profound Medical in Q4 2020 and held it in 6 quarters.
  • Susquehanna International Group's Profound Medical position peaked at $466K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.